FdaApplication

ANDA 205205

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMYLAN PHARMACEUTICALS INC
application_typeANDA
approval_date2024-01-19

Products (2)

ProductActive ingredientStrengthDosage form
DEXLANSOPRAZOLEDEXLANSOPRAZOLE60MGCAPSULE, DELAYED RELEASE;ORAL
DEXLANSOPRAZOLEDEXLANSOPRAZOLE30MGCAPSULE, DELAYED RELEASE;ORAL

2 products